Benzinga | Jul 14, 2020 12:53PM EDT

Heron Therapeutics Registers New Phase 2 Clinical Trail For Aprepitant Injectable Emulsion In Patients With Coronavirus

https://clinicaltrials.gov/ct2/show/NCT04470622